NCT02653300View on ClinicalTrials.gov

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

April 1, 2020

Conditions
Non-Alcoholic Steatohepatitis (NASH)Type2 Diabetes Mellitus
Interventions
BIOLOGICAL

Oral Insulin

all patients will receive treatment regimen of a soft gel capsule of ORMD-0801.

Trial Locations (1)

Unknown

Hadassah Medical Center, Jerusalem

All Listed Sponsors
collaborator

Hadassah Medical Organization

OTHER

lead

Oramed, Ltd.

INDUSTRY

NCT02653300 - A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter